Amylase
Amylase is a digestive enzyme that catalyses the breakdown of complex carbohydrates, particularly starch, into smaller sugars such as maltose and dextrins. Medicinal amylase preparations are used as digestive enzyme supplements to support carbohydrate digestion in selected cases of digestive discomfort or enzyme insufficiency, depending on the product formulation and approved indication. Amylase is commonly derived from microbial or other biological sources and may be included in combination products containing enzymes such as lipase and protease. It is available in oral formulations, including tablets, capsules, and digestive enzyme preparations. Possible adverse effects include nausea, abdominal discomfort, diarrhoea, and hypersensitivity reactions, depending on the formulation and source. The appropriate use depends on the underlying digestive condition, and persistent abdominal symptoms should be evaluated by a healthcare professional.
Amylase was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Amylase, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Amylase from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Amylase, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
